Jefferies Downgrades JCR Pharmaceuticals to Hold From Buy, Adjusts Price Target to 1,200 Yen From 1,800 Yen
Jefferies Downgrades JCR Pharmaceuticals to Hold From Buy, Adjusts Price Target to 1,200 Yen From 1,800 Yen
杰富瑞将JCR Pharmicals的评级从买入下调至持有,将目标股价从1,800日元调整至1,200日元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册